|
1
|
Hartmann C, Meyer J, Balss J, Capper D,
Mueller W, Christians A, Felsberg J, Wolter M, Mawrin C, Wick W, et
al: Type and frequency of IDH1 and IDH2 mutations are related to
astrocytic and oligodendroglial differentiation and age: A study of
1010 diffuse gliomas. Acta Neuropathol. 118:469–474. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Gravendeel LA, Kloosterhoof NK, Bralten
LB, van Marion R, Dubbink HJ, Dinjens W, Bleeker FE, Hoogenraad CC,
Michiels E, Kros JM, et al: Segregation of non-p.R132H mutations in
IDH1 in distinct molecular subtypes of glioma. Hum Mutat.
31:E1186–E1199. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Yan H, Parsons DW, Jin G, McLendon R,
Rasheed BA, Yuan W, Kos I, Batinic-Haberle I, Jones S, Riggins GJ,
et al: IDH1 and IDH2 mutations in gliomas. N Engl J Med.
360:765–773. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Watanabe T, Nobusawa S, Kleihues P and
Ohgaki H: IDH1 mutations are early events in the development of
astrocytomas and oligodendrogliomas. Am J Pathol. 174:1149–1153.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Bralten LB, Kloosterhof NK, Balvers R,
Sacchetti A, Lapre L, Lamfers M, Leenstra S, de Jonge H, Kros JM,
Jansen EE, et al: IDH1 R132H decreases proliferation of glioma cell
lines in vitro and in vivo. Ann Neurol. 69:455–463. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Lu C, Ward PS, Kapoor GS, Rohle D, Turcan
S, Abdel-Wahab O, Edwards CR, Khanin R, Figueroa ME, Melnick A, et
al: IDH mutation impairs histone demethylation and results in a
block to cell differentiation. Nature. 483:474–478. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Nobusawa S, Watanabe T, Kleihues P and
Ohgaki H: IDH1 mutations as molecular signature and predictive
value of secondary glioblastomas. Clin Cancer Res. 15:6002–6007.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sanson M, Marie Y, Paris S, Idbaih A,
Laffaire J, Ducray F, El Hallani S, Boisselier B, Mokhtari K,
Hoang-Xuan K, et al: Isocitrate dehydrogenase 1 codon 132 mutation
is an important prognostic biomarker in gliomas. J Clin Oncol.
27:4150–4154. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Hartmann C, Hentschel B, Wick W, Capper D,
Felsberg J, Simon M, Westphal M, Schackert G, Meyermann R, Pietsch
T, et al: Patients with IDH1 wild type anaplastic astrocytomas
exhibit worse prognosis than IDH1-mutated glioblastomas and IDH1
mutation status accounts for the unfavourable prognostic effect of
higher age: Implications for classification of gliomas. Acta
Neuropathol. 120:707–718. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Van den Bent MJ, Hartmann C, Preusser M,
Ströbel T, Dubbink HJ, Kros JM, von Deimling A, Boisselier B,
Sanson M, Halling KC, et al: Interlaboratory comparison of IDH
mutation detection. J Neurooncol. 112:173–178. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Capper D, Zentgraf H, Balss J, Hartmann C
and von Deimling A: Monoclonal antibody specific for IDH1 R132H
mutation. Acta Neuropathol. 118:599–601. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Kato Y, Jin G, Kuan CT, McLendon RE, Yan H
and Bigner DD: A monoclonal antibody IMab-1 specifically recognizes
IDH1 R132H, the most common glioma-derived mutation. Biochem
Biophys Res Commun. 390:547–551. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Kaneko MK, Tian W, Takano S, Suzuki H,
Sawa Y, Hozumi Y, Goto K, Yamazaki K, Kitanaka C and Kato Y:
Establishment of a novel monoclonal antibody SMab-1 specific for
IDH1-R132S mutation. Biochem Biophys Res Commun. 406:608–613. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Kaneko MK, Morita S, Tsujimoto Y, Yanagiya
R, Nasu K, Sasaki H, Hozumi Y, Goto K, Natsume A, Watanabe M, et
al: Establishment of novel monoclonal antibodies KMab-1 and MMab-1
specific for IDH2 mutations. Biochem Biophys Res Commun. 432:40–45.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kato Y, Natsume A and Kaneko MK: A novel
monoclonal antibody GMab-m1 specifically recognizes IDH1-R132G
mutation. Biochem Biophys Res Commun. 432:564–567. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Cui G, Ding H, Xu Y, Li B and Wang DW:
Applications of the method of high resolution melting analysis for
diagnosis of Leber's disease and the three primary mutation
spectrum of LHON in the Han Chinese population. Gene. 108–112.
2013. View Article : Google Scholar
|
|
17
|
Harle A, Lion M, Lozano N, Husson M,
Harter V, Genin P and Merlin JL: Analysis of PIK3CA exon 9 and 20
mutations in breast cancers using PCR-HRM and PCR-ARMS: Correlation
with clinicopathological criteria. Oncol Rep. 29:1043–1052.
2013.PubMed/NCBI
|
|
18
|
Parsons DW, Jones S, Zhang X, Lin JC,
Leary RJ, Angenendt P, Mankoo P, Carter H, Siu IM, Gallia GL, et
al: An integrated genomic analysis of human glioblastoma
multiforme. Science. 321:1807–1812. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Johnson BE, Mazor T, Hong C, Barnes M,
Aihara K, McLean CY, Fouse SD, Yamamoto S, Ueda H, Tatsuno K, et
al: Mutational analysis reveals the origin and therapy-driven
evolution of recurrent glioma. Science. 343:189–193. 2014.
View Article : Google Scholar :
|
|
20
|
Capper D, Weissert S, Balss J, Habel A,
Meyer J, Jäger D, Ackermann U, Tessmer C, Korshunov A, Zentgraf H,
et al: Characterization of R132H mutation-specific IDH1 antibody
binding in brain tumors. Brain Pathol. 20:245–254. 2010. View Article : Google Scholar
|
|
21
|
Agarwal S, Sharma MC and Jha P, Pathak P,
Suri V, Sarkar C, Chosdol K, Suri A, Kale SS, Mahapatra AK and Jha
P: Comparative study of IDH1 mutations in gliomas by
immunohistochemistry and DNA sequencing. Neuro Oncol. 15:718–726.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Agarwal S, Sharma MC, Jha P, Pathak P,
Suri V, Sarkar C, Chosdol K, Suri A, Kale SS, Mahapatra AK, et al:
Comparative study of IDH1 mutations in gliomas by
immunohistochemistry and DNA sequencing. Neuro Oncol. 15:718–726.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Kurian KM, Haynes HR, Crosby C, Hopkins K
and Williams M: IDH mutation analysis in gliomas as a diagnostic
and prognostic biomarker. Br J Neurosurg. 27:442–445. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Takano S, Tian W, Matsuda M, Yamamoto T,
Ishikawa E, Kaneko MK, Yamazaki K, Kato Y and Matsumura A:
Detection of IDH1 mutation in human gliomas: Comparison of
immunohistochemistry and sequencing. Brain Tumor Pathol.
28:115–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wittwer CT: High-resolution DNA melting
analysis: Advancements and limitations. Hum Mutat. 30:857–859.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Lin J, Qian J, Yao DM, Li Y, Yang J, Chen
Q, Chai HY, Xiao GF and Xu WR: Rapid and reliable detection of IDH1
R132 mutations in acute myeloid leukemia using high-resolution
melting curve analysis. Clin Biochem. 44:779–783. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Takano S, Tian W, Matsuda M, Yamamoto T,
Ishikawa E, Kaneko MK, Yamazaki K, Kato Y and Masumura A: Detection
of IDH1 mutation in human gliomas: Comparison of
immunohisto-chemistry and sequencing. Brain Tumor Pathol.
28:115–123. 2011. View Article : Google Scholar : PubMed/NCBI
|
